Skip to content

Clinical trials

Inflammation trials in Norway with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Not applicable Country / region: Norway Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20111
20131
20152
20171
20182
20191
20201
20211
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Oslo3
Helse Stavanger HF2
Oslo University Hospital2
Arctic Nutrition AS1
Diakonhjemmet Hospital1
Epax Norway AS1
Sykehuset Innlandet HF1
University Hospital of North Norway1
University Hospital, Akershus1
University of Bergen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation15
Cognitive Dysfunction2
Coronary Artery Disease2
Arthritis, Rheumatoid1
Atherosclerosis1
COVID-191
Cardiovascular Diseases1
Carotid Artery Diseases1
Carotid Stenosis1
Coronary Disease1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.